Key facts
- It has raised $14.6M; the latest was Later Stage VC ($2.4M) in Nov 2024.
- Notable investors include Innovate UK, Scottish Enterprise, The Scottish National Investment Bank, Alba Equity, BiP Solutions — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for PneumoWave
- ·The full record, as it builds
Funding rounds
No funding rounds for PneumoWave are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PneumoWave
Developer of digital therapeutics intended for real-time respiratory depression monitoring. The company provides proprietary algorithms to accurately detect a range of respiratory adverse events, biosensor continuously captures data and transmit it wirelessly for analysis, and an alert system promptly notifies healthcare providers, enabling doctors and nurses to facilitate a paradigm shift in respiratory care focusing on intervention before disease or injury has advanced.
- Sector
- Healthcare
- HQ
- Glasgow, United Kingdom
- Founded
- 2018
- Employees
- 23
- Website
- pneumowave.com/
- Ownership
- Privately Held (backing)
PneumoWave doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PneumoWave shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PneumoWave in its N-PORT filings yet. We sweep new filings monthly.